BPC-157 / GHK-Cu / KPV blend
Gut and tissue repair blend
A supplier blend of BPC-157, GHK-Cu and KPV in one vial, sold for gut and tissue repair.
Regulatory status: Not a medicine. None of the three components is approved for this use, and the combination has never been studied.
Default vial
30 mg
Default mix
3 mL
Reported range
Varies with the blend ratio
Draw (U-100)
5 u
Three compounds in one vial. Each is covered by its own entry; none has a human dosing trial. Blend ratios vary by supplier, so the mg of each component has to come off your COA before any dose figure means anything.
Where these numbers come from
No human dosing trial defines a dose for this compound. The numbers here are the values community calculators pre-fill — reference only. None of the three components has a human dosing trial, and the blend ratio varies by supplier — check the COA for the mg of each.
Reviewed October 2026
What it is
- Three separate compounds in a single vial: BPC-157, GHK-Cu and KPV. Each has its own Pep-Tidy entry, and that is where the evidence for each one sits.
- The ratio is chosen by the supplier. There is no standard formulation, so the mg of each component has to be read off the certificate of analysis.
- Marketed on the premise that the three act on different parts of tissue repair.
- Investigational components only — none has a human dosing trial.
How it is described to act
- 1
Given as a single subcutaneous injection containing all three.
- 2
Each component then behaves as it does on its own; the vial does not change their individual pharmacology.
- 3
The proposed rationale is complementary mechanisms, but no published study tests whether combining them adds anything.
- 4
No outcome has been measured for the combination.
What the research has looked at
What the research covers
- The published work studies each component separately, and all of it is animal or cell research. See the BPC-157, GHK-Cu and KPV entries for what each one actually shows.
- No published study tests this combination, so any claim that the three work better together than apart is an assumption.
Why the ratio matters
- A single “500 mcg of blend” figure says nothing about how much of each compound is in that dose.
- Two products sold under the same name can differ several-fold in the amount of any one component.
Strength of evidence: Preclinical evidence only
No study tests this combination. The components individually have animal and cell research only.
What is published comes from cell and animal studies. Findings in those models frequently do not carry over to people.
Reported cautions and unknowns
- A blend is several compounds at once, so an adverse effect cannot be traced to any one of them. Running components separately first is the only way to know which does what.
- Ratios are set by the supplier, not by any standard, so two vials with the same name can contain quite different amounts.
- The safety of the combination has not been studied. What is known, where anything is known, applies to each compound on its own.
- There are no combined pharmacokinetic or toxicity data for any of these blends, so interaction risk is unquantified.
- The FDA's 2026 compounding-committee briefing on BPC-157 documented adverse-event reports and gaps in impurity characterisation for that single peptide.
- Sterility, identity and concentration of multi-peptide compounded vials vary by supplier; only a current third-party Certificate of Analysis can confirm what a vial actually contains.
References
There are none. A search of the published literature returns no studies of this compound — no human trials, no animal work, no cell studies. Anything claimed about it elsewhere is not drawn from published research on this molecule.
Handling this vial
- Lyophilized vials are generally stored at 2–8 °C and kept out of light; once reconstituted with bacteriostatic water they are refrigerated and commonly discarded after 28 days.
- Mix by aiming water down the vial wall and rolling gently — do not shake — and never re-freeze a reconstituted vial.
- Pep-Tidy cannot verify what is in your vial. Ask your supplier for a current Certificate of Analysis (HPLC/MS).
BPC-157 / GHK-Cu / KPV blend questions people ask
How do you reconstitute BPC-157 / GHK-Cu / KPV blend?
A common starting point for a 30 mg vial of BPC-157 / GHK-Cu / KPV blend is 3 mL of bacteriostatic water, which gives 10 mg per mL. Aim the water down the inside wall of the vial, let it dissolve on its own, and roll gently instead of shaking. Pep-Tidy's reconstitution calculator will recalculate the numbers for any other vial size or water volume you use.
How many units of BPC-157 / GHK-Cu / KPV blend is one dose?
At 10 mg per mL, that works out to about 5 units on a U-100 insulin syringe for a 500 mcg dose. Change the vial size, water volume, or target dose in the calculator and the syringe reading updates with it. This is arithmetic, not a dosing recommendation.
What dosing schedule is reported for BPC-157 / GHK-Cu / KPV blend?
Published and community sources describe Varies with the blend ratio, subcutaneous, every day, typically run 4 weeks on and 2 weeks off. These figures describe what has been reported, not what anyone should take — talk to a licensed clinician first.
How should BPC-157 / GHK-Cu / KPV blend be stored?
Lyophilized BPC-157 / GHK-Cu / KPV blend vials are generally kept at 2–8 °C and out of light. Once reconstituted with bacteriostatic water they are refrigerated and commonly discarded after about 28 days. Never re-freeze a reconstituted vial and never shake it.
Read this before you act on anything above
Everything on this page is a summary of what other people have published — it is not medical advice, not a recommendation, and not a dosing instruction. Reported dose ranges describe what appears in the literature or in community protocols, not what anyone should take. Talk to a licensed clinician before using any peptide.